| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
ORIGINAL ARTICLE |
University Childrens Hospital Munich, Ludwig-Maximilians-Universität, Lindwurmstr. 4, 80337 Munich, Germany
Correspondence to:
Correspondence to:
Dr J Liese, Universitäts-Kinderklinik im Dr. v. Haunerschen Kinderspital, Ludwig-Maximilians-Universität, Lindwurmstr. 4, 80337 Munich, Germany;
Johannes.Liese{at}kk-i.med.uni-muenchen.de
Aims: To investigate the clinical picture and frequency of Bordetella pertussis and B parapertussis infections after introduction of acellular pertussis (acP) vaccines in Germany.
Methods: Prospective surveillance for B pertussis and B parapertussis in 14 144 toddlers. Pertussis vaccination coverage was 86%, either with acP (75%) or whole cell pertussis (wcP) vaccine (11%). All children presenting with cough for more than seven days were examined for B pertussis and B parapertussis by culture, PCR, and serology (for cough duration 
21 days).
Results: There were 180 Bordetella infections; 116 (64%) were caused by B pertussis and 64 (36%) by B parapertussis. Incidence rates were 4.8 and 2.8 per 1000 person-years, respectively. Paroxysmal cough, post-tussive whooping, and vomiting 21 days was found in 53%, 22%, and 8% of all B pertussis cases and in 22%, 5%, and 0% of all B parapertussis cases, respectively. A total of 81/116 (70%) B pertussis cases and 56/64 (87.5%) B parapertussis cases had received at least one dose of pertussis vaccine. Typical pertussis with paroxysmal cough 21 days was present in 29/35 (83%) unvaccinated B pertussis cases, in contrast to 33/81 (41%) vaccinated B pertussis cases.
Conclusion: Following the increase of pertussis vaccination coverage, we observed a relative increase of B parapertussis cases in comparison to B pertussis cases. In vaccinated children B pertussis disease frequently presented as a mild disease, clinically difficult to distinguish from diseases associated with coughing caused by B parapertussis and other viral or bacterial infections.
Keywords: B pertussis; B parapertussis; epidemiology; incidence; pertussis vaccine
This article has been cited by other articles:
|
|
 |
|
  E. M. Goebel, D. N. Wolfe, K. Elder, S. Stibitz, and E. T. Harvill O Antigen Protects Bordetella parapertussis from Complement Infect. Immun., April 1, 2008; 76(4): 1774 - 1780. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Wolfe, E. M. Goebel, O. N. Bjornstad, O. Restif, and E. T. Harvill The O Antigen Enables Bordetella parapertussis To Avoid Bordetella pertussis-Induced Immunity Infect. Immun., October 1, 2007; 75(10): 4972 - 4979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Chang and W. B. Glomb Guidelines for Evaluating Chronic Cough in Pediatrics: ACCP Evidence-Based Clinical Practice Guidelines Chest, January 1, 2006; 129(1_suppl): 260S - 283S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Wolfe, G. S. Kirimanjeswara, and E. T. Harvill Clearance of Bordetella parapertussis from the Lower Respiratory Tract Requires Humoral and Cellular Immunity Infect. Immun., October 1, 2005; 73(10): 6508 - 6513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mattoo and J. D. Cherry Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies Clin. Microbiol. Rev., April 1, 2005; 18(2): 326 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Illustrations, not run, but still fun! Arch. Dis. Child., December 1, 2003; 88(12): 1140 - 1141. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| ARCH DIS CHILD | FETAL NEONATAL ED | ED PRACTICE |
